Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12409227
Cochleates made with soy phosphatidylserine
granted -
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12410153
Compounds, compositions and methods
granted -
US 12410249
Low dose antibody-based methods for treating hematologic malignancies
granted -
US 12410399
Compositions and methods for treating retinal diseases
granted -
US 12410240
Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
granted -
US 12409188
Modulators of HSD17B13 expression
granted -
US 12409220
Conjugate polypeptides and vaccines for inducing immune responses
granted -
US 12410170
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
granted -
US 12410137
Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof
granted -
US 12409167
Pharmaceutical combination comprising a selective S1P1 receptor agonist
granted -
US 12410132
Antiplatelet drugs and uses thereof
granted -
US 12409225
Ras inhibitors
granted -
US 12409205
Nanomolecules for the treatment of inflammatory bowel diseases
granted -
US 12409228
Hydrogel drug delivery systems for the treatment of pediatric growth plate injuries
granted -
US 12410232
Treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12409181
Treatment for aortic aneurysms
granted -
US 12409213
Live attenuated oral vaccine against shigellosis and typhoid fever
granted -
US 12410231
Natural killer cell products and methods
granted -
US 12410259
CD47 targeted therapies for the treatment of infectious disease
granted -
WO 2025184490
N-[4-FLUOR-5-[[(2S,4R)-4-[(6-MÉTHOXY-4-PYRIMIDNYL)OXY]-2-MÉTHYL-1-PYRROLIDINYL]MÉTHYL]-2-THIAZOLYL]ACÉTAMIDE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
granted -
US 12404318
Combination HBV therapy
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.